Clinical Trial Update: Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing indocyanine green (ICG) distribution in the margins after tumor resection for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED